# FDA Inspection 1051652 - KBI Biopharma, Inc. - April 11, 2018

Source: https://www.globalkeysolutions.net/records/fda_inspections/kbi-biopharma-inc/5932eca4-bc32-4948-90a3-7be684abefc9/
Source feed: FDA_Inspections

> FDA Inspection 1051652 for KBI Biopharma, Inc. on April 11, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1051652
- Company Name: KBI Biopharma, Inc.
- Inspection Date: 2018-04-11
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1312108 - 2026-04-01](https://www.globalkeysolutions.net/api/records/fda_inspections/kbi-biopharma-inc/c23fd1bf-6113-4a1b-956d-885f190a4130/)
- [FDA Inspection 937768 - 2015-07-16](https://www.globalkeysolutions.net/api/records/fda_inspections/kbi-biopharma-inc/2a24b57f-300f-49d3-b234-78ecaded8d95/)
- [FDA Inspection 796226 - 2012-08-29](https://www.globalkeysolutions.net/api/records/fda_inspections/kbi-biopharma-inc/afcc769a-43bd-4ff3-a80b-aba4b1c1848e/)
- [FDA Inspection 625271 - 2009-10-09](https://www.globalkeysolutions.net/api/records/fda_inspections/kbi-biopharma-inc/6a0866c2-378e-428b-8824-cf305300302d/)

Company: https://www.globalkeysolutions.net/companies/kbi-biopharma-inc/c19eb9d6-d05c-437c-b018-992dba71d288

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c